Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLUMBER: LY2624803 in Insomnia
NCT00784875Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2008
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY-2624803 in Insomnia, sponsored by Eli Lilly and Company. Started Oct 2008; status: completed.
02
Drugs
LY-2624803
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT00784875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00784875.